Organ donors in the United States do not get paid. Federal law explicitly bans buying or selling human organs, and that prohibition applies to both living and deceased donation. What donors can receive, however, is reimbursement for certain expenses they incur during the process, and the line between “compensation” and “reimbursement” is where most of the real-world confusion lives. The distinction matters because thousands of potential donors face genuine financial hardship from the act of donating, and how society handles that cost shapes who ends up donating and who doesn’t.
What the Law Actually Says
The National Organ Transplant Act of 1984, known as NOTA, makes it a federal crime to transfer any human organ “for valuable consideration” when the purpose is transplantation. The penalty can include up to five years in prison and a $50,000 fine. This law was passed after a physician with a revoked medical license appeared before Congress in 1983 pitching a business called International Kidney Exchange, Ltd., which planned to buy kidneys from people in developing countries or from disadvantaged Americans at whatever price would persuade them to sell.1PubMed. Financial compensation for organ donors The outcry was swift, and Congress moved to shut down any commercial market before one could take root.
The law does, however, carve out room for removing what it calls “financial disincentives.” That means you can be reimbursed for travel, lodging, lost wages, and childcare costs tied to your donation without anyone breaking the law. The legal reasoning is that reimbursement restores you to the financial position you were in before you donated, rather than putting you ahead. Courts have reinforced this distinction, noting that organ donation is legally a gift: by definition, no “consideration” changes hands in a gift transaction, and reimbursing someone’s out-of-pocket costs doesn’t turn a gift into a sale.2American Journal of Transplantation. The Region 1 UNOS Kidney Transplant Protocol
The Real Costs of Being a Living Donor
Even though living donors don’t pay for the surgery itself (the recipient’s insurance covers that), the surrounding expenses add up fast. A systematic review of the economic costs facing living kidney donors found that the average sum of select costs in one U.S. study came to about $840 per donor, but the range was enormous, stretching from zero to nearly $29,000.3Nephrology Dialysis Transplantation. The direct and indirect economic costs incurred by living kidney donors—a systematic review Travel and accommodation were the most common expenses, affecting anywhere from 9 to 99 percent of donors depending on how far they lived from the transplant center. Between 14 and 30 percent of donors reported losing income, with average losses in the thousands of dollars.
These aren’t trivial numbers for people who are already stretching a budget. Childcare, household help during recovery, and prescription painkillers after discharge all pile on. The review found that post-discharge painkillers were needed by roughly a quarter of donors in some studies, but prescription costs weren’t even tracked. The picture that emerges is one of scattered, poorly documented costs that vary wildly by geography, employment situation, and family circumstances.
How the Government Helps With Expenses
To address those costs without crossing the legal line into payment, the federal government funds the National Living Donor Assistance Center, or NLDAC. Established through a grant from the Health Resources and Services Administration, the center operates a nationwide system specifically designed to cover travel, lodging, and other non-medical expenses for living donors who meet income qualifications. By the time one study assessed its early track record, the center had received close to 4,000 applications from nearly 200 transplant centers, with about 80 new applications arriving every month. The average donor spent roughly $2,800 on travel expenses alone to get to and from their transplant center.4PubMed Central. Development of the National Living Donor Assistance Center: reducing financial disincentives to living organ donation
From a government spending perspective, this program looks like a bargain. An analysis of about 2,400 approved NLDAC applications found that the program cost roughly $6.8 million to run, but the kidney transplants it helped facilitate saved Medicare between five and 28 times that amount, depending on whether you looked at one-year or five-year savings. The total came to an estimated $256 million in federal savings, because each transplant averts years of dialysis, which Medicare covers and which costs far more than the transplant surgery itself.5PubMed. Return on investment for financial assistance for living kidney donors in the United States
State-Level Protections and Why They Haven’t Moved the Needle Much
Beyond the federal program, many states have passed their own laws offering paid leave for organ donors, tax deductions or credits for donation-related expenses, or both. By 2006, 27 states had enacted some form of donor-support legislation. The idea seems logical: if you remove the financial sting, more people will donate. But the evidence on whether these laws actually increase organ donation is surprisingly thin.
A national study covering living kidney donation from 1988 to 2006 found no statistically significant jump in overall living kidney donation rates after states passed their legislation. The annual increase in donations per million people was essentially the same before and after the laws took effect. There was one bright spot: the laws did appear to boost living-unrelated donation, meaning donations between people who aren’t family members, which suggests they may have lowered barriers for altruistic strangers even if they didn’t change behavior among relatives.6PubMed Central. The association of state and national legislation with living kidney donation rates in the United States: a national study
A separate study examining both organ and bone marrow donation came to a similar conclusion for organs but found that leave laws did measurably increase bone marrow donations. The researchers suggested that the financial incentives embedded in state legislation may work for less invasive procedures like marrow donation but are simply too small relative to the burden of organ donation, which involves major surgery, weeks of recovery, and ongoing health risks.7PubMed. Removing financial barriers to organ and bone marrow donation: the effect of leave and tax legislation in the U.S. In other words, a few days of paid leave and a modest tax break may not be enough to offset the weight of giving up a kidney.
What the Public Actually Thinks About Paying Donors
Public opinion on compensating donors is more nuanced than you might expect. A large U.S. survey found that an overwhelming majority of respondents supported reimbursing medical costs and providing paid leave for living donors. Over half also favored giving living donors or their family members priority on the organ waiting list if they ever needed a transplant themselves. But when the question shifted to direct financial payment, support dropped sharply. Fewer than one in five respondents believed that deceased donors’ families should receive compensation, with 78 percent saying no outright.8American Journal of Transplantation. Public Attitudes Toward Incentives for Organ Donation
Racial and ethnic background influenced these views. Non-Hispanic White respondents were less likely to support family compensation after donation than non-Hispanic African Americans, Hispanics, and people of other racial backgrounds. The gap was meaningful: about 8 percent of White respondents favored it, compared to 17 percent of African Americans. For living donors specifically, government tax breaks and direct payments attracted support from fewer than half of respondents, while employer compensation during recovery was somewhat more popular.
A European survey explored a different angle, asking respondents to choose between two specific compensation models: lifelong health insurance for the donor or a lump-sum cash payment of €25,000. People preferred the health insurance option, particularly when it was paired with a system where donors registered at an independent institute rather than being recruited by patients. That preference hints at an intuition many people share: non-cash benefits feel less like buying an organ than handing someone a check.9Nephrology Dialysis Transplantation. Public survey of financial incentives for kidney donation
Proposals That Stop Short of a Market
Several reform proposals try to thread the needle between compensating donors and maintaining the principle that organs aren’t for sale. One common idea is offering living kidney donors a package of non-cash benefits: tax credits, lifelong health insurance, tuition assistance, or contributions to a retirement fund.10PubMed Central. Reciprocating living kidney donor generosity: tax credits, health insurance and an outcomes registry The deliberate use of delayed, non-cash compensation is meant to avoid attracting people who are desperate for immediate money, which is the scenario critics fear most when they oppose paying donors.11PLoS ONE. Would government compensation of living kidney donors exploit the poor? An empirical analysis
For deceased donation, one idea gaining attention is funeral expense reimbursement. A recent analysis proposed amending NOTA to allow covering funeral costs for deceased organ donors, similar to what already happens when families donate a body to medical science. The researchers estimated this could increase organ donation rates by 9 to 35 percent, potentially saving hundreds of thousands of life-years and generating between $200 million and $800 million annually in Medicare savings.12PubMed Central. Funeral expense reimbursement as a strategy to enhance organ donation and transplantation access The argument leans on a simple asymmetry: medical schools routinely cover funeral or cremation costs for whole-body donors without anyone calling it organ trafficking, so extending the same courtesy to transplant donors shouldn’t cross an ethical line either.
Economists have gone further, modeling what a regulated market might look like. One analysis estimated that monetary incentives could eliminate transplant waiting lists entirely without raising the total cost of transplant surgery by more than about 12 percent, because the price of a kidney on a regulated market would be modest compared to the overall expense of the procedure.13Journal of Economic Perspectives. Introducing Incentives in the Market for Live and Cadaveric Organ Donations These proposals remain politically untouchable in the United States, but they continue to shape the academic debate.
Does Payment Actually Exploit Poor People?
The strongest objection to paying organ donors is that it would prey on the poor: people who would never choose surgery voluntarily would feel forced into it by financial need. This concern drives much of the opposition to any form of compensation beyond bare-bones reimbursement. But the empirical evidence on this point is less clear-cut than the moral argument suggests.
A study designed specifically to test whether financial payment would distort decision-making found that payment did not disproportionately influence people based on their income level or their perception of risk. The statistical interaction between payment and income was essentially zero, and the same was true for the interaction between payment and risk perception. The researchers interpreted this as evidence that regulated compensation is neither an “undue inducement” (overriding people’s better judgment) nor an “unjust inducement” (targeting the vulnerable).14PubMed Central. Regulated payments for living kidney donation: an empirical assessment of the ethical concerns
Meanwhile, the current no-payment system already has a socioeconomic tilt, just in the opposite direction. In the United Kingdom, a study of kidney transplant access found that increasing social deprivation was associated with sharply lower odds of receiving a living donor transplant. People in the most deprived areas had only about 40 percent the odds of getting a living donor kidney compared to those in the least deprived areas. Black and South Asian patients younger than 50 also had significantly lower odds.15Transplantation. Social Deprivation, Ethnicity, and Uptake of Living Kidney Donor Transplantation in the United Kingdom The irony is that the system designed to protect poor people from exploitation may also be the system that makes it hardest for them to find living donors, because the financial burden of donating falls most heavily on communities with the least money to absorb it.
Iran’s Experiment With Paid Kidney Donation
Only one country has operated a government-regulated system of paid living kidney donation for an extended period: Iran. Starting in 1988, Iran adopted a compensated, regulated program for living-unrelated kidney transplants. By 1999, the country had completely eliminated its kidney transplant waiting list, something no other nation has achieved. By the end of 2005, Iran had performed over 19,600 kidney transplants, the vast majority from living-unrelated donors.16PubMed. Iranian model of paid and regulated living-unrelated kidney donation
The program works through a government-supervised nonprofit that matches donors and recipients, with the government paying a fixed compensation and providing free health insurance to donors. The amount is modest by Western standards. Supporters point to the elimination of the waiting list and claim the program avoided many of the ethical pitfalls associated with unregulated organ sales. Critics counter that the system still draws donors overwhelmingly from lower-income backgrounds and that the Iranian context is too different from Western healthcare systems to serve as a model. Still, the program’s longevity and its impact on wait times make it impossible to ignore in any serious discussion of donor compensation.
The Black Market Problem
Where legal compensation doesn’t exist, illegal markets fill the gap. Organ trafficking and transplant tourism remain persistent global problems. Over the past three decades, numerous international bodies have called for prohibitions on paid organ removal, and most countries now explicitly ban and criminalize organ trade. The Declaration of Istanbul, first adopted in 2008 and updated in 2018, serves as the primary international framework, calling on every country to establish transparent regulatory systems that protect donors and recipients while enforcing prohibitions on trafficking.17PubMed. The implications of Istanbul Declaration on organ trafficking and transplant tourism
Despite these efforts, enforcement remains uneven. Several countries have had to strengthen their laws in recent years to close loopholes that made it difficult to prosecute people profiting from transplant-related crimes.18PubMed Central. Strengthening Global Efforts to Combat Organ Trafficking and Transplant Tourism: Implications of the 2018 Edition of the Declaration of Istanbul The persistence of black markets is itself an argument used by both sides of the compensation debate. Opponents say any form of payment would normalize organ sales and make trafficking harder to distinguish from legal transactions. Proponents argue that the black market exists precisely because legal channels don’t offer enough incentive, and that a regulated, transparent system would undercut the criminal one.
Insurance and Career Concerns After Donation
One worry that potential donors rarely voice publicly but think about privately is whether donating an organ will make them uninsurable or hurt their career. The Affordable Care Act bars health insurers from denying coverage or charging more based on pre-existing conditions, which protects living donors in the health insurance market. Life and disability insurance operate under different rules, though, and donors have historically worried about being penalized.
The available evidence is reassuring on this front. A study of living liver donors, who undergo a more invasive procedure than kidney donors, found that they held life insurance, disability insurance, and medical insurance at rates comparable to the general population. Only small proportions reported difficulty obtaining these types of coverage: 9 percent for life insurance, 9 percent for disability, and 4 percent for medical.19PubMed. Living Liver Donation Does not Significantly Affect Long-Term Life, Disability, or Medical Insurability Those numbers aren’t zero, and individual experiences vary, but they suggest that donation doesn’t routinely slam the door on insurability the way many prospective donors fear.
Federal legislation has also moved to strengthen these protections. The Living Donor Protection Act, versions of which have been introduced in Congress multiple times, aims to prohibit life and disability insurers from discriminating against living donors and to guarantee job-protected leave under the Family and Medical Leave Act for the recovery period. As of now, these protections remain a patchwork, varying by state and by the type of insurance involved.